000			00967 a2200289 4500
005			20250516025117.0
264		0	_c20111025
008			201110s 0 0 eng d
022			_a0423-104X
040			_aNLM _beng _cNLM
100	1		_aFranek, Edward
245	0	0	_aDenosumab--a new option in the treatment of osteoporosis. _h[electronic resource]
260			_bEndokrynologia Polska _c
300			_a79-83 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBone Density Conservation Agents _xtherapeutic use
650	0	4	_aDenosumab
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aOsteoporosis, Postmenopausal _xdrug therapy
650	0	4	_aRANK Ligand _xtherapeutic use
773	0		_tEndokrynologia Polska _gvol. 62 _gno. 1 _gp. 79-83
999			_c20639105 _d20639105